Sp1 mediates microRNA-29c-regulated type I collagen production in renal tubular epithelial cells

Experimental Cell Research

Volumn 319, Issue 14, 2013, Pages 2254-2265

  Jiang, Lei ^a   Zhou, Yang ^a   Xiong, Mingxia ^a   Fang, Li ^a   Wen, Ping ^a   Cao, Hongdi ^a   Yang, Junwei ^a   Dai, Chunsun ^a   He, Weichun ^a  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

MicroRNA 29c; Renal fibrosis; Specificity protein 1; Tubular epithelial cell; Type I collagen

Indexed keywords

COLLAGEN TYPE 1; MICRORNA; MICRORNA 29C; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DOWN REGULATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; URETER OBSTRUCTION; WESTERN BLOTTING;

EID: 84880712697     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.06.007     Document Type: Article

References (48)

1. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat. Rev. 2011, 7:684-696.
2. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.
3. Bottinger E.P., Bitzer M. TGF-beta signaling in renal disease. J. Am. Soc. Nephrol. 2002, 13:2600-2610.
4. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J. Am. Soc. Nephrol. 2010, 21:212-222.
5. Chu S. Transcriptional regulation by post-transcriptional modification-role of phosphorylation in Sp1 transcriptional activity. Gene 2012, 508:1-8.
6. Lee M., Song S.U., Ryu J.K., Suh J.K. Sp1-dependent regulation of the tissue inhibitor of metalloproteinases-1 promoter. J. Cell Biochem. 2004, 91:1260-1268.
7. Sysa P., Potter J.J., Liu X., Mezey E. Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell Biol. 2009, 28:425-434.
8. Bermudez Y., Yang H., Saunders B.O., Cheng J.Q., Nicosia S.V., Kruk P.A. VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent. Gynecol. Oncol. 2007, 106:526-537.
9. Motojima M., Ando T., Yoshioka T. Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells. Biochem. J. 2000, 349:435-441.
10. Park J.H., Jo J.H., Kim K.H., Kim S.J., Lee W.R., Park K.K., Park J.B. Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis. J. Gene Med. 2009, 11:824-833.
11. Kum Y.S., Kim K.H., Park T.I., Suh I.S., Oh H.K., Cho C.H., Park J.B., Chang Y.C., Park J.H., Lee K.G., Park K.K. Antifibrotic effect via the regulation of transcription factor Sp1 in lung fibrosis. Biochem. Biophys. Res. Commun. 2007, 363:368-374.
12. Chae Y.M., Park K.K., Lee I.K., Kim J.K., Kim C.H., Chang Y.C. Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction. Gene Ther. 2006, 13:430-439.
13. Verrecchia F., Rossert J., Mauviel A. Blocking sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis. J. Invest. Dermatol. 2001, 116:755-763.
14. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
15. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C., Volinia S., Guler G., Morrison C.D., Chan K.K., Marcucci G., Calin G.A., Huebner K., Croce C.M. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA 2007, 104:15805-15810.
16. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
17. van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., Hill J.A., Olson E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 2008, 105:13027-13032.
18. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M.A., Licht J.D., Pena J.T., Rouhanifard S.H., Muckenthaler M.U., Tuschl T., Martin G.R., Bauersachs J., Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
19. Cushing L., Kuang P.P., Qian J., Shao F., Wu J., Little F., Thannickal V.J., Cardoso W.V., Lu J. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2011, 45:287-294.
20. Roderburg C., Urban G.W., Bettermann K., Vucur M., Zimmermann H., Schmidt S., Janssen J., Koppe C., Knolle P., Castoldi M., Tacke F., Trautwein C., Luedde T. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology (Baltimore, Md) 2011, 53:209-218.
21. Chu A.S., Friedman J.R. A role for microRNA in cystic liver and kidney diseases. J. Clin. Invest. 2008, 118:3585-3587.
22. Chung A.C., Huang X.R., Meng X., Lan H.Y. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J. Am. Soc. Nephrol. 2010, 21:1317-1325.
23. Wang B., Komers R., Carew R., Winbanks C.E., Xu B., Herman-Edelstein M., Koh P., Thomas M., Jandeleit-Dahm K., Gregorevic P., Cooper M.E., Kantharidis P. Suppression of microRNA-29 Expression by TGF-beta1 Promotes Collagen Expression and Renal Fibrosis. J. Am. Soc. Nephrol. 2012, 23:252-265.
24. Qin W., Chung A.C., Huang X.R., Meng X.M., Hui D.S., Yu C.M., Sung J.J., Lan H.Y. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J. Am. Soc. Nephrol. 2011, 22:1462-1474.
25. Maurer B., Stanczyk J., Jungel A., Akhmetshina A., Trenkmann M., Brock M., Kowal-Bielecka O., Gay R.E., Michel B.A., Distler J.H., Gay S., Distler O. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum. 2010, 62:1733-1743.
26. Yang J., Dai C., Liu Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J. Am. Soc. Nephrol. 2002, 13:2464-2477.
27. Xiong M., Jiang L., Zhou Y., Qiu W., Fang L., Tan R., Wen P., Yang J. The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am. J. Physiol. Renal Physiol. 2012, 302:F369-379.
28. He W., Tan R., Dai C., Li Y., Wang D., Hao S., Kahn M., Liu Y. Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling. J. Biol. Chem. 2010, 285:24665-24675.
29. He W., Kang Y.S., Dai C., Liu Y. Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J. Am. Soc. Nephrol. 2011, 22:90-103.
30. Jiang L., Qiu W., Zhou Y., Wen P., Fang L., Cao H., Zen K., He W., Zhang C., Dai C., Yang J. A microRNA-30e/mitochondrial uncoupling protein 2 axis mediates TGF-beta1-induced tubular epithelial cell extracellular matrix production and kidney fibrosis. Kidney Int. 2013.
31. He W., Dai C., Li Y., Zeng G., Monga S.P., Liu Y. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J. Am. Soc. Nephrol. 2009, 20:765-776.
32. Lania L., Majello B., De Luca P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 1997, 29:1313-1323.
33. Berg J.M. Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc. Natl. Acad. Sci. USA 1992, 89:11109-11110.
34. Cook T., Gebelein B., Urrutia R. Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors. Ann. N. Y. Acad. Sci. 1999, 880:94-102.
35. Artlett C.M., Chen S.J., Varga J., Jimenez S.A. Modulation of basal expression of the human alpha1(I) procollagen gene (COL1A1) by tandem NF-1/Sp1 promoter elements in normal human dermal fibroblasts. Matrix Biol. 1998, 17:425-434.
36. Miao K., Potter J.J., Anania F.A., Rennie-Tankersley L., Mezey E. Effect of acetaldehyde on Sp1 binding and activation of the mouse alpha 2(I) collagen promoter. Arch. Biochem. Biophys. 1997, 341:140-152.
37. Ihn H., Ohnishi K., Tamaki T., LeRoy E.C., Trojanowska M. Transcriptional regulation of the human alpha2(I) collagen gene, combined action of upstream stimulatory and inhibitory cis-acting elements. J. Biol. Chem. 1996, 271:26717-26723.
38. Chung K.Y., Agarwal A., Uitto J., Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J. Biol. Chem. 1996, 271:3272-3278.
39. Tamaki T., Ohnishi K., Hartl C., LeRoy E.C., Trojanowska M. Characterization of a GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the alpha 2(I) collagen gene in human fibroblasts. J. Biol. Chem. 1995, 270:4299-4304.
40. Pogulis R.J., Freytag S.O. Contribution of specific cis-acting elements to activity of the mouse pro-alpha 2(I) collagen enhancer. J. Biol. Chem. 1993, 268:2493-2499.
41. Haase M., Geyer P., Appold S., Schuh D., Kasper M., Muller M. Down-regulation of SP1 DNA binding activity in the process of radiation-induced pulmonary fibrosis. Int. J. Radiat. Biol. 2000, 76:487-492.
42. Hitraya E.G., Varga J., Artlett C.M., Jimenez S.A. Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis. Arthritis Rheum. 1998, 41:2048-2058.
43. Rippe R.A., Almounajed G., Brenner D.A. Sp1 binding activity increases in activated Ito cells. Hepatology (Baltimore, Md) 1995, 22:241-251.
44. Zhang W., Ou J., Inagaki Y., Greenwel P., Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription. J. Biol. Chem. 2000, 275:39237-39245.
45. Wang B., Koh P., Winbanks C., Coughlan M.T., McClelland A., Watson A., Jandeleit-Dahm K., Burns W.C., Thomas M.C., Cooper M.E., Kantharidis P. miR-200a Prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes 2011, 60:280-287.
46. Kato M., Arce L., Wang M., Putta S., Lanting L., Natarajan R. A microRNA circuit mediates transforming growth factor-beta1 autoregulation in renal glomerular mesangial cells. Kidney Int. 2011, 80:358-368.
47. Inui M., Martello G., Piccolo S. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 2010, 11:252-263.
48. Ogawa T., Iizuka M., Sekiya Y., Yoshizato K., Ikeda K., Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem. Biophys. Res. Commun. 2010, 391:316-321.